Abstract: The present invention relates to the treatment or prevention of SARS-COV-2 infection or COVID-19. In particular, the present invention relates to the use of N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide, or a pharmaceutically acceptable salt thereof, in the treatment or prevention of SARS-COV-2 infection or COVID-19.

Abstract: The present invention relates to Fms-like tyrosine kinase (FLT3) inhibitors. The present invention provides novel 4-quinolinone derivatives used as FLT3 inhibitors and for treatment and/or prevention of tumors.

Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.

Abstract: The present invention relates to the treatment or prevention of influenza virus infection. In particular, the present invention relates to the use of N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide, or a pharmaceutically acceptable salt thereof, in the treatment or prevention of influenza virus infection.

Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.

Abstract: The present invention relates to the treatment or prevention of influenza virus infection. In particular, the present invention relates to the use of N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide, or a pharmaceutically acceptable salt thereof, in the treatment or prevention of influenza virus infection.

Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.

Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.

Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.

Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.

Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.

Abstract: A carbon dioxide gas mist pressure bath apparatus for preventing, improving or curing an ischemic disease by contacting a carbon dioxide gas mist to a skin and a mucous membrane of a living organism directly or through a clothing, thereby to improve or promote a circulation of a blood in an ischemic region, includes a carbon dioxide gas mist-enclosing unit; a gas supply unit for supplying a carbon dioxide gas; a carbon dioxide gas mist generating and supplying unit for pulverizing and dissolving the carbon dioxide gas into a liquid, and supplying the carbon dioxide gas mist into the carbon dioxide gas mist-enclosing unit; an exhausting device for exhausting the gas in the carbon dioxide gas mist-enclosing unit to an outside thereof; and a control device for controlling a supplying amount of the carbon dioxide gas mist from the carbon dioxide gas mist generating and supplying unit.

Abstract: A carbon dioxide gas mist pressure bath apparatus for preventing, improving or curing a myocardial infarction by contacting a carbon dioxide gas mist to a skin and a mucous membrane of a living organism directly or through a clothing, thereby to improve or promote a circulation of a blood, includes a carbon dioxide gas mist-enclosing unit for enclosing the living organism; a gas supply unit for supplying a carbon dioxide gas; a carbon dioxide gas mist generating and supplying unit for pulverizing and dissolving the carbon dioxide gas into a liquid, and supplying the carbon dioxide gas mist into the carbon dioxide gas mist-enclosing unit; an exhausting device for exhausting the gas in the carbon dioxide gas mist-enclosing unit to an outside thereof; and a control device for controlling a supplying amount of the carbon dioxide gas mist from the carbon dioxide gas mist generating and supplying unit.

Abstract: The invention relates to compounds having antiviral activity and methods utilizing the compounds to treat viral infections.

Abstract: The present invention relates to novel compositions having anti-viral activity and in particular it relates to synergistic compositions active against Hepatitis C virus (HCV). The invention also relates to methods for retarding, reducing or otherwise inhibiting HCV growth and/or functional activity.

Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.

Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.

Abstract: Methods, systems and devices are implemented in connection with measuring the relative content of intramuscular fat (IMF) in a portion of muscle tissue. Consistent with one such method a probe is presented to the portion of muscle tissue. The probe produces a response-provoking signal in the muscle tissue. A resulting signal is used to determine the relative content of IMF in the portion of muscle tissue as a function of the pressure being exerted between the probe and the portion.

Abstract: Methods, systems and devices are implemented in connection with measuring the relative content of intramuscular fat (IMF) in a portion of muscle tissue. Consistent with one such method a probe is presented to the portion of muscle tissue. The probe produces a response-provoking signal in the muscle tissue. A resulting signal is used to determine the relative content of IMF in the portion of muscle tissue as a function of a selected filter.

Abstract: Methods, systems and devices are implemented in connection with measuring characteristics of a portion of muscle tissue. Consistent with one such method an ultrasound probe is presented to the portion of muscle tissue. The probe produces a response-provoking signal in the muscle tissue, and the pressure applied between the probe and the portion of muscle tissue is sensed. A resulting signal is used to determine the muscle tissue characteristics based on the pressure being exerted between the probe and the portion. For example, the pressure data is associated with and used to filter the acquisition or use of ultrasound image data.